Back

Biventricular and atrial systolic function parameters as early predictors of cardiorespiratory fitness improvement in patients with heart failure

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Rehabilitation and sports cardiology Cardiovascular Rehabilitation HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Assistant Professor Cristina-Andreea Adam

Grigore T. Popa University of Medicine and Pharmacy, Iasi (Romania)

6 More presentations in this session

Presentation thumbnail
Proteomic profile of chronotropic incompetence differs between individuals with reduced and preserved left ventricular ejection fraction in heart failure
Miss N. Belanger (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Third ventilatory threshold in heart failure patients undergoing CPET: a prognostic analysis
Doctor J. Certo Pereira (Carnaxide, PT)
Abstract Slides Video
Presentation thumbnail
Cardiac remodeling after 6 weeks of sprint interval training in relation to changes in blood-volume parasympathetic drive.
Miss L. Eriksson (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Echospiroergometry: new diagnostic tool
Doctor L. Garcia Rodriguez (Malaga, ES)
Abstract Slides Video
Presentation thumbnail
Empowering elders with heart failure: a self-management program for chronic disease mastery.
Associate Professor R. Olszewski (Warsaw, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Rehabilitation and sports cardiology

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Cardiorespiratory outcomes of cardiac rehabilitation programs in heart failure patients with preserved left ventricular ejection fraction
thumbnail
Congress Presentation
Cardiorespiratory fitness through exercise-based cardiac rehabilitation: a comprehensive analysis in patients with heart failure.
thumbnail
Congress Presentation
Effectiveness of a cardiac rehabilitation program in patients with heart failure and skeletal muscle weakness

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources